Navigation Links
Nycomed US Inc. Acquires Bradley Pharmaceuticals, Inc.
Date:2/21/2008

MELVILLE, N.Y., Feb. 21 /PRNewswire/ -- Today, Nycomed US Inc. successfully completed the acquisition of Bradley Pharmaceuticals, Inc., a company focused on niche therapeutic markets in the United States. With this acquisition, Nycomed will expand the line of dermatological products currently offered through its PharmaDerm Division and thereby increase market coverage and drive future growth. Combined with Nycomed's Fougera Division, which is a leader in the topical prescription market in the US, total annualized sales will be $450 million, making Nycomed a leader in the dermatology market. Additionally, the combined specialty sales force now places Nycomed among the top five in sales forces selling prescription therapeutics in the US dermatology market.

Bradley's success over the years has been largely due to its strength in identifying and developing new products through life cycle management. Now, with the addition of this successful pipeline strategy, the collective sales and marketing capabilities, and the combined product offerings, Nycomed is well positioned as a leading specialty pharmaceutical player in the US dermatological market.

Nycomed also expects that the acquisition will provide an enhanced platform for in-licensing and co-promotion of dermatology products, which in turn will build revenues, optimize costs, and increase efficiency.

Nycomed has announced that the PharmaDerm headquarters will be located in Florham Park, New Jersey. The Company will be transitioning key employees from Bradley's Fairfield corporate headquarters building to Florham Park over the next several months. Nycomed anticipates that the organizations will be fully integrated by year-end.

Paul McGarty, CEO of Nycomed US, said of the merger, "We are excited about the new opportunities that the merger with Bradley Pharmaceuticals will bring to Nycomed US. The combined commercial organization will bring strength and focus to our PharmaDerm Division.
'/>"/>

SOURCE Nycomed US Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Nycomeds Ciclesonide to be Commercialised in the United States by Sepracor
2. NPS Pharmaceuticals to Report Third Quarter 2007 Financial Results and Nycomed Decision on GATTEX(TM) Partnership on November 1, 2007
3. Sirion Therapeutics Acquires Worldwide License to Develop New Treatment for Ocular Diseases
4. Setaram Inc. Acquires Hy-Energy LLC
5. Alexion Acquires All Rights to OMRF Patents Related to Soliris(R)
6. Linc Facility Services Acquires Morse Medical
7. Acrongenomics Acquires Equity Stake in Molecular Vision
8. Inverness Medical Innovations Acquires ParadigmHealth
9. LeMaitre Vascular Acquires Biomateriali, a Vascular Graft Manufacturer
10. Thermo Fisher Scientific Acquires Leading Chromatography Consumables Provider, La-Pha-Pack
11. Raptor Pharmaceuticals Acquires Orphan Clinical Program

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Ambassador to also Visit Detroit...009 -- , , ,Who: David Appia, French Ambassador fo...f the Invest in France Agency, , , , ,What: Ambas...cuss recent pro-business initiatives adopted by Fr...academic landscape for innovation and development....
(Date:11/24/2009)...CALGARYandBLENHEIM,Ontario,Nov.24/PRNewswire-First...iringtheassetsofHylandSeeds,adivisionofThompsonsLi...llfurtherexpandDowAgroSciences,currentseedsbusines...x(TM) in 2010 andDowAgroSciencesHerbicideToleran...isexpectedinthenearfuture. ,, "Thisacquisitionb...
(Date:11/24/2009)... Health care employment grew by... only one to show consistent growth during the U.S...als remain in trouble, and health systems are comi...nel, instead of just administrators. , ...care employment continued growing in October despi...
(Date:11/24/2009)...SANMATEO,Calif.,Nov.24/PRNewswire-FirstCall/--Neur...yfocusedondevelopingandcommercializingnovelpainman...PresidentandChiefExecutiveOfficer,isscheduledtopre...e,tobeheldDecember1-2,2009atTheNewYorkPalaceHoteli...eri,ChiefFinancialOfficer,willbeavailabletorespond...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
...ce microscope, the tiny structures look like fragm...e pearls are fullerene molecules that are linked t...lecule. Spanish researchers describe their method ... of the journal Angewandte Chemie. , Fullerenes ar... atoms whose linkages resemble the five- and six-s...
... GAITHERSBURG, Md., Nov. 30 Binex,(KOSDAQ: 053030... a,Sponsored Research Agreement to evaluate MaxCyt...in closed-system manufacturing of Binex,s,cell-bas...research studies,the agreement provides Binex an o... and commercial use in Korea. Financial terms were...
... BioSpace, the leading online,source for life sci...hird,edition of the BioForest(TM) Hotbed Campaign.... Hotbed Map and also functional components to work...velopment initiatives of,Washington, Oregon, Idaho... and Manitoba., (Photo: http://www.newscom.com/c...
Other Biology Technology:Binex and MaxCyte Collaborate on Cancer Immunotherapy Research 2BioSpace Launches 3rd Edition of BioForest(TM) Bioscience Marketing Campaign 2
(Date:11/23/2009)...esents strong evidence that the "synergistic" effe...related pollution and indoor endotoxin causes more...posure alone. , Environmental health scientist...Medicine have shown that children exposed to both ...r endotoxin during early life are six times more l...
(Date:11/23/2009)...an 160 participants gathered this week for the sev...TIVE conference. This year,s topic, "Synthetic Bio... medical researchers to explore the engineering, s...ing field of synthetic biology. , Bonnie L. Bass...niversity and this year,s conference chair, challe...
(Date:11/23/2009)... 2009 -- A USDOE and USDA study concluded that 50 ... cropland pasture could be converted from current ...as switchgrass, from which biomass could be harves...iable production of a perennial grass monoculture ...emoved annually is expected to require nitrogen fe...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Switchgrass produces biomass efficiently 2Hospira to Present at Piper Jaffray 21st Annual Health Care Conference Dec 2 60875 1Oxygen Biotherapeutics Inc Announces 1 3A15 Reverse Stock Split to Take Effect Nov 9 2009 6067 1Oxygen Biotherapeutics Inc Announces 1 3A15 Reverse Stock Split to Take Effect Nov 9 2009 6067 2Oxygen Biotherapeutics Inc Announces 1 3A15 Reverse Stock Split to Take Effect Nov 9 2009 6067 3McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL 28R 29 Arthritis Pain 100 Count with EZ OPEN CAP 6065 1McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL 28R 29 Arthritis Pain 100 Count with EZ OPEN CAP 6065 2
...pril 2, 2009 University College London Business P... held biopharmaceutical company, announced the sig... for UCL-L1V and all assets and technologies relat...tic encephalopathy (AHE). , The compound recent...els of ammonia, a highly toxic chemical that build...
...ersity of Rochester have developed a novel optical...uman immune cells using only light. , Availabilit... other cellular researchers may soon be able to ob... stimuli, rather than relying on aggregate statist...scientists have not had a non-invasive way to see ...
...versity of Illinois report that IDO, an enzyme fou...ng a role in depression, is in fact essential to t... inflammation. , Their study, just published onl...o identify IDO (indoleamine 2,3 dioxygenase) as a ...in some cases of chronic inflammation. , Doctors ...
Other Biology News:Ocera Therapeutics licenses novel treatment for acute hepatic encephalopathy from UCLB 2Ocera Therapeutics licenses novel treatment for acute hepatic encephalopathy from UCLB 3Distinguishing single cells with nothing but light 2Distinguishing single cells with nothing but light 3Team identifies a molecular switch linking infectious disease and depression 2Team identifies a molecular switch linking infectious disease and depression 3
Anti-4-hydroxy-2-hexenal Monoclonal Antibody, Unconjugated from Cosmo Bio Co., Ltd.
Anti-Human VEGFR-2 / KDR Antibody, Unconjugated from Cell Sciences
Rabbit Anti-Human Tankyrase 2 (TNKL (TNKS2) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
...olved in translation initiation. PHAS-II is highes...E, the mRNA cap-binding protein, and inhibit trans...horylation in the appropriate site(s) promotes dis...F-4E to bind to eIF-4G (p220), thereby increasing ...
Biology Products: